Subsequently, we found that patients with structural variants in CD274 UTR region who responded to immune checkpoint inhibitors were all positive for PD-L1 expression validated by mIF method, which confirmed the immune escape behavior of tumor cells. Here, CD274 is linked to neoplasm.